Binge Eating Disorder.

Slides:

Advertisements

Similar presentations

Eating Disorders Chapter 11. Severe disruptions in normal eating patterns & a significant disturbance in the perception of body shape and weight Can often.

Advertisements

Upfront Combination Therapy vs Step-Up Approach for PAH:

Major Depressive Disorder: Latest Clinical Update

A Practical Guide to the Prevention of Surgical Adhesions

Bipolar I Depression Today: The Evolving Understanding of Bipolar Depression Neurobiology and the Relation to Diagnosis.

RESISTANT HYPERTENSION OR POOR PATIENT ADHERENCE? TIPS TO GAIN CONTROL

NOACs In Long-term VTE Treatment: A State Of The Art Review

What Is Major Depressive Disorder (MDD)?

Exploring the Spectrum of Excessive Daytime Sleepiness

This program will include a discussion of off-label treatment and devices and investigational agents and devices not approved by the FDA for use in the.

MANAGING GLAUCOMA:.

At The Cutting Edge of Developments in the Management of Hyperkalemia

The Patient Journey to Remission in MDD: A Collaborative Approach

Understanding the Many Faces of Pseudobulbar Affect

Optimizing Quality of Life and Mental Health in Patients With Psoriasis.

Select Topics in Cardiovascular Medicine

Managing Complex Hypertension: What Every Physician Should Know

Program Goals. Consulting the Experts: Prandial Insulin or a GLP-1 Receptor Agonist as Add-On to Basal Insulin.

Neurogenic Orthostatic Hypotension: Expert Perspectives on Diagnosis and Treatment Strategies.

Case Challenges in Chronic Migraine

Resistant Hypertension

Managing Hard-To-Treat Hypertension: What Every Physician Should Know

Diagnosis and Management of Narcolepsy in Psychiatry:

Global Burden of VTE. Preventing Thrombosis During and Post-Hospitalization: New Paradigms in Clinical Care.

The Mood Disorder Spectrum

What Would You Do in This Case of MDD?

When Patients With Depression Have Cognitive Deficits

Screening and Diagnosing Postpartum Depression

Improving Risk Assessment and Early Diagnosis in PAH

Updates in Pulmonary Arterial Hypertension

Activity Goals. Activity Goals Case Presentation.

Novel Insulin Combinations: What Does the Primary Care Physician Need to Know?

WHO Clinical Classification of PH Complex Cases in PH.

Program Goals. Treatment-Naive Patients With PAH What Do We Know and What Choices Do We Have?

Learning Objectives Classification of VTE Goals of VTE Treatment.

Hyperhidrosis Is Burdensome!

Demographics of IPF in the USa-d

Examining the Latest Evidence in PAH

Pseudobulbar Affect or Psychiatric Condition?

Insights Into the Spectrum of Tardive Dyskinesia

Using Heart Rate as a Biomarker in Clinical Practice.

EARLY Combination Therapy in PAH: What Every Cardiologist Needs to Know.

Staying Abreast of Best Practices Across the Clinical Continuum

Getting to Grips With the Science of CGRP and Migraine

Factor Xa Inhibitors in PAD

After the Baby Comes.

New Approaches to Insomnia Management: Impact on Clinical Practice

New ELN Recommendations

Oral Prostacyclin Pathway Agents in PAH

Etiology and Incidence Pathophysiology Hemophilia is due to a defect in thrombin generation on the platelet surface.

Incorporating Prostacyclins Into Practice

The Rising Crisis of Prediabetes Diagnosis and Management of the Patient With Prediabetes.

Program Goals Background: Anticoagulation in Patients With VTE.

The ABCs of Pharmacogenomics in Clinical Practice

Patient Stories in PAH: Sequential Therapy in a FC II Patient

Prostacyclin Pathway Agents in Action

AMD Therapy: Where Are We Now and Where Are We Going?

VTE Treatment and Secondary Prevention VTE Treatment Trials Initial Dosing.

PAH Pathways: What Do the Data Tell Us?”

Championing Evidence-Based Care in Patients With Acute Low Back Pain

Introduction. Welcome to this program, titled De-Escalating Therapy in Epilepsy: A Return to Monotherapy.

Importance of Early Diagnosis and Management in SMA

Tardive Dyskinesia 101.

Expert Insights in Diagnosis and Management of Common Drug-Induced Movement Disorders.

My PAH Patient.

Understanding the Basics of Dementia-Related Psychosis

The Power of As-Treated Analyses

What's New in NOACs in AF?.

Management of NTM Lung Disease

Diagnosing HFpEF: What Every Cardiologist Needs to Know

Presentation transcript:

Binge Eating Disorder

Binge Eating Disorder

Who Gets BED?

Etiology of BED

Diagnosis DSM-5 Criteria

DSM-5 Severity

BED vs Other Eating Disorders

BED Diagnostic Caveats

Context Is Important

Screening Tools

Physical Comorbidities

Prevalence of Psychiatric Comorbidities

Burden of BED Functional Impairment

Treatment Non-Pharmacological

Treatment Pharmacological

LDX Clinical Trial Acute

LDX Clinical Trial Acute (cont)

LDX Clinical Trial Maintenance

LDX Clinical Trial Maintenance (cont)

Other Agents Studied for BED

Agent in Clinical Trial

Dasotraline Clinical Trial Flexible Dose

Dasotraline Clinical Trial Fixed Dose

Dasotraline Clinical Trial Fixed Dose (cont)

Dasotraline Clinical Trial Secondary Outcomes

Dasotraline Clinical Trial Secondary Outcomes (cont)

Combination Therapy

Conclusions

Abbreviations